Drug Trial Radar · NCT01955720
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
Last checked: Nov 20, 2026Latest source record: Feb 11, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Sep 2013
Primary completion
May 2014
Study completion Aug 2014
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Oct 7, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 45 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To investigate safety, tolerability, PK and PD of BI 655075 and to establish the BI 655075 dose(s) effective to reverse prolongation of blood coagulation time by dabigatran
Conditions
- Hemorrhage
Interventions
BI 655075Drug
BI 655075Drug
PlaceboDrug
BI 655075Drug
PlaceboDrug
PlaceboDrug
PlaceboDrug
BI 655075Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reversal of Dabigatran-induced Prolongation of Blood Coagulation TimeTime frame: End of last infusion and 10 minutes after completion of last infusion of BI 655075
- The Percentage of Subjects With Drug-related Adverse EventsTime frame: From baseline up to the start of follow-up period (from Day 1 to Day 35)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
1321.2.1 Boehringer Ingelheim Investigational Site
Antwerp, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.